Colorado Lawmakers and Activists Push for Wide-Ranging Psychedelic Reform
Trio of lawmakers propose a psychedelic reform review panel, while two ballot initiatives push legalization and licensed “healing centers.”
Trio of lawmakers propose a psychedelic reform review panel, while two ballot initiatives push legalization and licensed “healing centers.”
Biggest difference between the two proposed bills: one decriminalizes plant medicine.
A Republican in Missouri and two Democrats in Virginia file bills that push the psychedelics movement forward.
This week in psychedelic business news: Another psychedelics company starts trading on OTCQB; another ketamine trial delivers; and another patent is issued.
Awakn Life Sciences’ Head of Ketamine-Assisted Therapy, Professor Celia Morgan, says world’s first controlled trial to investigate efficacy of ketamine-assisted therapy for treatment of Alcohol Use Disorder “paves the way for a paradigm shift.”
This week in psychedelic business news: Mindset Pharma partners with global pharmaceutical company; Awakn Life Sciences explores behavioral addictions; Ei.Ventures buys virtual land for psychedelic therapy.
“The Matrix” was always an allegory for awakening to your full potential, and the fourth sequel creates the proper set and setting to dive even further through the looking glass.
This week in psychedelic business news: FDA green lights a new psilocybin study; MindMed commences LSD treatment for ADHD; Sage Institute shuffles leadership.
This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints new CEO; MAPS and Wesana Health resume negotiations.
“Establishing a widespread route to provide New Yorkers with this medical treatment would be a monumental step in providing mental health care to improve lives,” reads the bill.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.